Home > Balance Sheet > BIOCON

BIOCON
Total Non-Current Liabilities

    Back to Balance Sheet
BIOCON is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
COMMUNITY POLL
for BIOCON
Please provide your vote to see the results

BIOCON Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Total Non-Current Liabilities ₹12,404 Cr₹16,493 Cr₹15,120 Cr₹20,742 Cr₹6,803 Cr

What is the latest Total Non-Current Liabilities ratio of BIOCON ?

The latest Total Non-Current Liabilities ratio of BIOCON is ₹12,404 Cr based on Mar2026 Consolidated results.
Year Total Non-Current Liabilities
Mar2026₹12,404 Cr
Mar2025₹16,493 Cr
Mar2024₹15,120 Cr
Mar2023₹20,742 Cr
Mar2022₹6,803 Cr

How is Total Non-Current Liabilities of BIOCON Trending?

Years Total Non-Current Liabilities % Change
Mar2026 ₹12,404 Cr
-24.79
Mar2025 ₹16,493 Cr
9.08
Mar2024 ₹15,120 Cr
-27.11
Mar2023 ₹20,742 Cr
204.91
Mar2022 ₹6,803 Cr -

Compare Total Non-Current Liabilities of peers of BIOCON

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BIOCON ₹63,973.9 Cr -2.2% -8.7% 8.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹451,339.0 Cr -2.7% -3.7% 20.3% Stock Analytics
DIVIS LABORATORIES ₹254,068.0 Cr 3.7% 15.7% 51% Stock Analytics
TORRENT PHARMACEUTICALS ₹188,767.0 Cr -0.8% 1% 36.2% Stock Analytics
CIPLA ₹111,804.0 Cr -2.1% -5.2% -11.6% Stock Analytics
DR REDDYS LABORATORIES ₹96,113.4 Cr -0.8% -0.5% -9.3% Stock Analytics


BIOCON Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BIOCON

-2.2%

-8.7%

8.9%

SENSEX

-1.8%

-3.7%

-5.7%


You may also like the below Video Courses